New pill combo challenges standard antidepressants in Head-to-Head trial

NCT ID NCT06957223

Completed Symptom relief Sponsor: Asad Ullah Jan Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a combination of dextromethorphan and bupropion works better than standard SSRI antidepressants for major depression. 80 adults with moderate to severe depression were randomly assigned to one of the two treatments for 6 weeks. Researchers measured changes in depression scores and remission rates to see which approach was more effective and tolerable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dextromethorphan-bupropion combination
What this could lead to: If this works, it could offer a new treatment option for people with major depression who don't respond well to standard SSRIs.
What could go wrong: This is a small, completed trial with only 80 participants and a short 6-week treatment period. Results may not apply to everyone, and the combination may have side effects like dizziness or nausea.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MAJOR DEPRESSIVE DISORDER (MDD)

Contacts and locations

Locations

Combined Military Hospital

Nowshera, KPK, 25770, Pakistan
Department of Psychiatry, Combined Military Hospital Nowshera

Nowshera, KPK, 25770, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.